TESAURO, MANFREDI
 Distribuzione geografica
Continente #
NA - Nord America 44.361
AS - Asia 5.512
EU - Europa 4.822
SA - Sud America 801
Continente sconosciuto - Info sul continente non disponibili 593
AF - Africa 134
OC - Oceania 41
Totale 56.264
Nazione #
US - Stati Uniti d'America 44.154
SG - Singapore 2.208
CN - Cina 1.022
IT - Italia 973
BR - Brasile 682
RU - Federazione Russa 645
DE - Germania 608
UA - Ucraina 543
HK - Hong Kong 536
IE - Irlanda 404
VN - Vietnam 397
FR - Francia 390
IN - India 277
GB - Regno Unito 274
PL - Polonia 240
BD - Bangladesh 229
FI - Finlandia 221
SE - Svezia 206
KR - Corea 188
JP - Giappone 152
CA - Canada 113
NL - Olanda 93
IR - Iran 74
ID - Indonesia 71
TR - Turchia 62
PK - Pakistan 58
AR - Argentina 41
BE - Belgio 40
MX - Messico 40
EG - Egitto 37
ZA - Sudafrica 36
IQ - Iraq 31
AU - Australia 28
ES - Italia 27
CZ - Repubblica Ceca 25
TH - Thailandia 24
PH - Filippine 23
SA - Arabia Saudita 23
MY - Malesia 21
UZ - Uzbekistan 19
AE - Emirati Arabi Uniti 18
AT - Austria 18
PR - Porto Rico 18
RO - Romania 18
CO - Colombia 17
EC - Ecuador 16
LT - Lituania 15
MA - Marocco 15
VE - Venezuela 15
NZ - Nuova Zelanda 13
PT - Portogallo 13
KG - Kirghizistan 12
NP - Nepal 12
TW - Taiwan 12
CL - Cile 10
EU - Europa 10
KE - Kenya 10
AL - Albania 9
CH - Svizzera 8
IL - Israele 8
JM - Giamaica 8
RS - Serbia 8
TN - Tunisia 8
DK - Danimarca 7
DZ - Algeria 7
GR - Grecia 7
KZ - Kazakistan 7
PE - Perù 7
PY - Paraguay 7
AZ - Azerbaigian 5
BG - Bulgaria 5
CR - Costa Rica 5
GT - Guatemala 4
HN - Honduras 4
JO - Giordania 4
MT - Malta 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
GH - Ghana 3
HU - Ungheria 3
NI - Nicaragua 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
A1 - Anonimo 2
BN - Brunei Darussalam 2
BZ - Belize 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
HR - Croazia 2
LB - Libano 2
NG - Nigeria 2
QA - Qatar 2
SV - El Salvador 2
Totale 55.657
Città #
Woodbridge 12.199
Wilmington 10.641
Houston 9.972
Fairfield 1.420
Singapore 1.332
Ashburn 1.039
Ann Arbor 876
Chandler 798
Seattle 554
San Jose 523
Hong Kong 494
Jacksonville 466
Cambridge 430
New York 357
Dublin 354
Beijing 347
Rome 309
Dearborn 305
Council Bluffs 299
Medford 293
Kraków 204
Santa Clara 190
Los Angeles 187
The Dalles 146
Lawrence 135
Tokyo 128
Ho Chi Minh City 126
Dallas 118
Lauterbourg 112
Hanoi 93
Moscow 92
Menlo Park 91
Zhengzhou 89
Buffalo 88
San Diego 73
São Paulo 72
Helsinki 70
Milan 70
London 58
Munich 52
Orem 45
Saint Petersburg 45
North Bergen 43
Shanghai 41
Atlanta 40
Mülheim 38
Montreal 37
Chicago 36
Frankfurt am Main 36
Norwalk 36
Redondo Beach 35
Hefei 33
Nuremberg 33
Boardman 31
Brussels 31
Chennai 31
Denver 31
Jakarta 31
Brooklyn 30
Phoenix 29
Lahore 27
Manchester 27
Warsaw 27
Falls Church 26
Columbus 25
Guangzhou 24
Johannesburg 24
Palo Alto 24
San Francisco 24
Nanjing 23
Toronto 23
Rio de Janeiro 21
Mountain View 20
Nürnberg 20
Seoul 20
Tehran 19
Amsterdam 18
Engelhard 18
Redwood City 18
Boston 17
Detroit 17
Mexico City 17
Naples 17
Stockholm 17
Washington 17
Brno 16
Haiphong 16
Lappeenranta 16
Turku 16
Bangkok 15
Miami 15
Poplar 15
Salt Lake City 15
Baghdad 14
Bayamón 14
Istanbul 14
Jinan 14
Ankara 13
Brasília 13
Da Nang 13
Totale 46.663
Nome #
Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance 627
Peroxiredoxin 6, a novel player in the pathogenesis of diabetes 602
Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome 534
Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients 533
Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology 520
Involvement of PRDX6 in the pathogenesis of obesity and nonalcoholic fatty liver disease 518
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy 516
Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects 507
Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects 498
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy 494
The possible role of glutathione-S-transferase activity in diabetic nephropathy 492
Decreased plasma adiponectin concentration in major depression 489
Insulin glargine in enteric tube feeding. 488
Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: Relations with eating patterns and circulating concentrations of cortisol and thyroid hormones 488
Analysis of the power of common diagnostic tools in the management of acute pancreatitis 487
SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α 484
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 482
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol 481
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy 481
Arterial ageing: from endothelial dysfunction to vascular calcification 479
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment 478
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity 474
The possible role of physical activity in the modulation of gut microbiota in chronic kidney disease and its impact on cardiovascular risk: a narrative review 473
Preoperative embolization reduces the risk of cathecolamines release at the time of surgical excision of large pelvic extra-adrenal sympathetic paraganglioma 472
Obesity and kidney disease: Beyond the hyperfiltration 469
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 466
Ghrelin improves endothelial function in patients with metabolic syndrome 464
Sildenafil reduces insulin-resistance in human endothelial cells 464
Preventive geriatrics the cross-talk between arterial and brain aging: A lifelong condition 463
Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects 461
Plasma Ghrelin in Anorexia, Bulimia, and Binge-Eating Disorder: Relations with Eating Patterns and Circulating Concentrations of Cortisol and Thyroid Hormones 461
Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia 461
Immune reaction and colorectal cancer: friends or foes? 453
Vasodilator Responses and Endothelin-Dependent Vasoconstriction in Metabolically Healthy Obesity and the Metabolic Syndrome 449
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual 448
Tumor necrosis factor-α antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 448
Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients 447
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 447
Gut hormones and endothelial dysfunction in patients with obesity and diabetes 445
Reduction of left ventricular hypertrophy detected by cardiac magnetic resonance in a patient after renal denervation 445
"The Linosa Study": Epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate 445
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome 443
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients 442
Obesity, blood vessels and metabolic syndrome 442
Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss 442
Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome 441
Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus 441
Beneficial Effects of Apelin on Vascular Function in Patients with Central Obesity 440
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol 439
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298 437
Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome 437
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans 437
[Endothelial dysfunction and diabetes: possible role in kidney damage] 437
Decreased plasma adiponectin concentration in major depression 435
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes 434
Cardiovascular and metabolic effects of ghrelin 433
Occurrence of Hypotension in Older Participants. Which 24-hour ABPM Parameter Better Correlate With? 431
Recent acquisitions on the pathophysiology of metabolic syndrome [Recenti progressi nelle conoscenze della patogenesi della sindrome metabolica] 430
Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes 430
Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes 429
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study 429
Human obesity and endothelium-dependent responsiveness 427
Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome 426
Clinical and electrical performance of currently available MRI-safe pacing systems. Do all devices perform in the same way? 424
Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells 421
Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells 421
Ghrelin improves endothelial function in patients with metabolic syndrome 421
Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study 420
CD26: a multi-purpose pharmacological target 418
Insulinemia and the risk of breast cancer and its relapse 417
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 416
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 415
Management of global cardiovascular risk in older subjects with diabetes mellitus 414
Obesity-related metabolic syndrome and vascular complications. 413
Metabolic and cardiovascular effects of ghrelin 413
Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome 412
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. 412
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia. 411
Vascular effects of insulin and their relation to endothelial dysfunction, insulin resistance and hypertension 411
Early detection of high voltage lead failure with an unusual and unexpected device alert 410
The Linosa Study: epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate 409
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome 409
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 407
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 406
The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications 406
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual 404
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. 403
Unexplained syncope in a patient with Brugada-like electrocardiogram. Lighting the dark side of underlying bradyarrhythmias 402
Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin 401
Obesity, inflammation and endothelial dysfunction 399
Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency 397
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 396
Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus 395
[Diabetes worsens the clinical manifestations and prognosis of concurrent cardiovascular and kidney disease] 395
Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines 393
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients 391
Vascular Effects of Obestatin in Lean and Obese Subjects 389
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B) 384
Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells 383
Insulin glargine in enteric tube feeding 383
Totale 44.436
Categoria #
all - tutte 131.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.502 0 151 74 69 69 154 116 97 129 129 98 416
2022/20231.973 174 188 89 225 154 410 180 133 174 18 125 103
2023/20241.251 123 63 78 47 100 317 174 71 25 83 48 122
2024/20253.773 164 699 383 307 214 233 274 221 390 355 312 221
2025/20266.677 549 341 769 580 641 177 916 706 724 651 341 282
2026/2027938 610 328 0 0 0 0 0 0 0 0 0 0
Totale 56.264